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The functional organization of eukaryotic genomes
correlates with specific patterns of histone methyla-
tions. Regulatory regions in genomes such as
enhancers and promoters differ in their extent of
methylation of histone H3 at lysine-4 (H3K4), but it
is largely unknown how the different methylation
states are specified and controlled. Here, we show
that the Kdm5c/Jarid1c/SMCX member of the
Kdm5 family of H3K4 demethylases can be recruited
to both enhancer and promoter elements in mouse
embryonic stem cells and in neuronal progenitor
cells. Knockdown of Kdm5c deregulates transcrip-
tion via local increases in H3K4me3. Our data indi-
cate that by restricting H3K4me3 modification at
core promoters, Kdm5c dampens transcription, but
at enhancers Kdm5c stimulates their activity.
Remarkably, an impaired enhancer function acti-
vates the intrinsic promoter activity of Kdm5c-bound
distal elements. Our results demonstrate that the
Kdm5c demethylase plays a crucial and dynamic
role in the functional discrimination between en-
hancers and core promoters.
INTRODUCTION
Themethylation state of lysines in histones has been linked to the
establishment and maintenance of epigenetic and transcrip-
tional states of genes (Bonasio et al., 2010; Greer and Shi,
2012). Transcription start sites (TSSs) are marked by trimethyla-
tion of lysine 4 of histone H3 (H3K4me3), which facilitates access
and assembly of RNA polymerase II (pol II) transcription com-
plexes (Vermeulen et al., 2007;Wysocka et al., 2006). In contrast,
H3K4me1 modification combined with acetylated H3K27
(H3K27ac) is predictive of active enhancers (Bonn et al., 2012;CBuecker and Wysocka, 2012; Creyghton et al., 2010; De Santa
et al., 2010; Ernst et al., 2011; Heintzman et al., 2007; Zentner
et al., 2011), which can regulate the transcriptional activity of
genes over larger genomic distances (Banerji et al., 1981; Bulger
and Groudine, 2011; Ong and Corces, 2011). A variety of protein
complexes capable of binding H3K4me3 have been identified,
but specific H3K4me1 binders seem sparse (Jeong et al.,
2011; Ruthenburg et al., 2007). Several SET-domain-containing
enzymes, including the SET1/MLL proteins (Ruthenburg et al.,
2007; Shilatifard, 2008), can achieve methylation of H3K4 to all
three states. It was reported very recently that the Trithorax-
related (Trr) protein from fruit flies, and by analogy the mamma-
lian MLL3/4 proteins, are particularly important for maintaining
global levels of H3K4me1 (Herz et al., 2012). H3K4 methylations
can be reversed by members of the Kdm5/Jarid1 family (for
K4me3/2 to K4me1) or Lsd/Kdm1 (for K4me2/1 to K4me0) family
of histone demethylases (Cloos et al., 2008; Secombe et al.,
2007). Genome-wide studies revealed that Kdm5a (also known
as [a.k.a.] Jarid1a/Rbp2) and Kdm5b (a.k.a. Jarid1b/Plu-1)
localize to promoter regions (Lopez-Bigas et al., 2008; Peng
et al., 2009; Schmitz et al., 2011). In contrast, Lsd1/Kdm1a binds
to both promoter and distal elements (Whyte et al., 2012), and
Lsd2/Kdm1b colocalizes with H3K36 methylation in the gene
bodies of actively transcribed genes (Fang et al., 2010). Recruit-
ment of H3K4 demethylases to specific genomic loci could be
mediated via intrinsic ‘‘reader’’ domains for modified chromatin
(Greer and Shi, 2012), but gene-specific transcription factors
also seem to be involved (Blair et al., 2011; Secombe et al.,
2007; Tahiliani et al., 2007).
Members of the Kdm5 family have distinct biological functions
(Blair et al., 2011; Varier and Timmers, 2011). Several studies
have shown a direct involvement of Kdm5a and Kdm5b in
cancer. Loss of Kdm5a inhibited tumorigenesis in a mouse
model (Lin et al., 2011). Also, Kdm5a is overexpressed in gastric
cancer and high levels of Kdm5b have been observed in breast
and prostate cancer (Blair et al., 2011; Varier and Timmers,
2011). Kdm5a and Kdm5b are involved in maintenance of a
slow-growing, drug-resistant population of cancer cells (Roeschell Reports 3, 1071–1079, April 25, 2013 ª2013 The Authors 1071
et al., 2010; Sharma et al., 2010). Other reports, however,
showed that Kdm5a is required for induction of cellular senes-
cence in several cell types (Chicas et al., 2012; Nijwening
et al., 2011). Knockout of Kdm5b, but not of Kdm5a, results in
early embryonic lethality in mice (Catchpole et al., 2011). The
role of Kdm5b in embryonic stem cells (ESCs) and their differen-
tiation is controversial. One study showed that Kdm5b knock-
down triggers differentiation and loss of self-renewal of ESCs
(Xie et al., 2011), whereas another study showed that although
knockout of the Kdm5b gene does not affect ESC growth or
morphology, Kdm5b is important for differentiation along the
neuronal lineage (Schmitz et al., 2011). The KDM5C gene
(a.k.a. SMCX or JARID1C) has been implicated in different
human diseases, such as renal cancer and X-linkedmental retar-
dation (Blair et al., 2011; Dalgliesh et al., 2010). Based on their
biochemical activity (me3/2 to me1), all of the Kdm5 members
are expected to act as transcriptional repressors, and studies
on Kdm5a and Kdm5b support this model (Blair et al., 2011;
Dey et al., 2008; Iwase et al., 2007). In light of these studies,
the genetic classification of the Kdm5 homolog from Drosophila
melanogaster, Lid, as a Trithorax-group type of gene activator
(Gildea et al., 2000) could be explained by a global increase of
H3K4me3 and redistribution of H3K3me3 binding proteins
such as CHD1 (Eissenberg et al., 2007).
To gain insights into the function of Kdm5c, we determined its
genomic distribution in both mouse ESCs and neuronal progen-
itor cells (NPCs). In addition, we profiled messenger RNA
(mRNA) expression and H3K4me1 and H3K4me3 chromatin
marks before and after Kdm5c knockdown in ESCs. Our results
indicate that transcriptional regulation by Kdm5c is dependent
on the genomic element bound. At promoters, Kdm5c restricts
transcriptional output, whereas Kdm5c binding to enhancers
stimulates their activity. In addition, our results stress the impor-
tance of H3K4 methylation states in the control of gene expres-
sion. We propose that the functional identity of transcription
regulatory regions in mammalian genomes is achieved through
balancing enzymes that deposit and remove histone H3K4
methylations.
RESULTS
Genome Localization of Kdm5c in Mouse ESCs and
NPCs Reveals Both Promoter-Proximal and
Promoter-Distal Binding
The Kdm5c demethylase protein is expressed in mouse ESCs
and NPCs. To determine the genomic localization of Kdm5c,
we expressed a biotinylated version of this protein via BAC
recombineering (Poser et al., 2008) in BirA-ESCs (Figures S1A–
S1E). This IB10-derived ESC line coexpresses the bacterial
BirA biotin ligase (Driegen et al., 2005), allowing highly selective
chromatin immunoprecipitation (ChIP; van Werven and Tim-
mers, 2006). NPCs were derived from the tagged ESC line and
immunoblot analysis showed that the tagged Kdm5c protein
is expressed to similar levels in NPCs compared with ESCs
(Figures S1E and S2A). Streptavidin purification of Kdm5c
crosslinked chromatin combined with deep sequencing identi-
fied 3,668 high-confidence Kdm5c-binding sites for ESCs and
6,656 for NPCs (false discovery rate [FDR] < 0.05). A total of1072 Cell Reports 3, 1071–1079, April 25, 2013 ª2013 The Authors1,224 binding sites were common to both ESCs and NPCs.
The accuracy of the ChIP sequencing (ChIP-seq) signals was
verified for a random selection of Kdm5c peaks by ChIP-PCR
(Figure S2B).
We also profiled H3K4me1 and H3K4me3 modifications in
ESCs, which indicated colocalization of Kdm5c with some, but
not all, of the peaks for H3K4me1 or H3K4me3 (Figure 1A). Clus-
tering analysis using our data sets and published data sets for
ESCs (Creyghton et al., 2010; Min et al., 2011; Peng et al.,
2009; Schnetz et al., 2010) indicated that Kdm5c binding over-
laps within regions of high, intermediate, or low levels of
H3K4me3 (Figure 1B). As expected, high H3K4me3 regions
(1/3 of the total) correspond to active promoters and these
regions also display with high signals for H3K27ac and for global
run-on sequencing (GRO-seq), which measures ongoing tran-
scription (Min et al., 2011). Indeed, the vast majority of these
regions localize close to a TSS (Figure 1C). In contrast, regions
with intermediate or low H3K4me3 levels contain lower but
significant H3K27ac or GRO-seq signals and are clearly positive
for H3K4me1. In addition, H3K27me3 is absent from these
regions (data not shown). This pattern corresponds to putative
intergenic enhancers (Buecker and Wysocka, 2012; Creyghton
et al., 2010; Ernst et al., 2011; Heintzman et al., 2009; Pekowska
et al., 2011; Zentner et al., 2011) and these Kdm5c peaks localize
mostly >5 kb from a TSS (Figure 1C). Enhancer proteins such as
p300 and Chd7 (Buecker and Wysocka, 2012; Creyghton et al.,
2010; Schnetz et al., 2010) are enriched at all Kdm5c binding
sites (Figures 1B and S3). Differentiation into NPCsmainly results
in loss of Kdm5c binding for regions with enhancer-like charac-
teristics (Figure 1B). Interestingly, binding of the Kdm5a paralog
(Peng et al., 2009) overlaps with Kdm5c at high H3K4me3
promoter regions, but not at the putative enhancers (Figure 1B).
In conclusion, Kdm5c localizes to both promoter- and enhancer-
like genomic elements in ESCs.
Kdm5c Can Interact with the Gene-Specific
Transcription Factors c-MYC and ELK1
Previous investigations of several Kdm5 demethylases revealed
interactions with gene-specific transcription factors, such as
REST and MYC, that could mediate their recruitment to specific
genomic loci (Blair et al., 2011; Secombe et al., 2007; Tahiliani
et al., 2007). To investigate chromatin localization for Kdm5c
in ESCs, we examined the ChIP-seq peaks for enrichment of
specific DNA sequences using the GREAT algorithm (McLean
et al., 2010). Unexpectedly, we observed no enrichment of
REST motifs in ESCs, and we also could not confirm previous
interactions of Kdm5c with the CoREST complex (Tahiliani
et al., 2007) in this cell system (data not shown). Instead,
Kdm5c peaks for high H3K4me3 regions are enriched for
DNA motifs of gene-specific transcription factors binding to
proximal promoters such as SP1, MYC, and ELK1 (Figure 2A).
In contrast, regions with intermediate H3K4me3 are enriched
for binding motifs for the GATA transcription factors (Fig-
ure 2A), which are typical enhancer pioneering factors (Zaret
and Carroll, 2011). Next, we compared the enrichment of
these sequence motifs with the Kdm5c binding strength. This
showed that the fraction of regions bearing binding sites for
MYC and ELK1 increases with the Kdm5c ChIP-seq signal
AB
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Figure 1. Kdm5c Binds to Promoters and Enhancers in Mouse ESCs
(A) Genome browser representation of the Kdm5c binding sites in ESCs and
NPCs with H3K4me1 and H3K4me3 profiles of ESCs.
(B) Heat maps of ChIP-seq signals (as indicated above) surrounding the 3,668
high-confidence (FDR < 0.05) Kdm5c binding sites (±5 kb) in ESCs. Regions
were classified into high-, intermediate-, or low-H3K4me3 categories. Color
scales are indicated below the columns.
(C) Genes linked to the genomic regions in the three categories are shown as
percentage of binding sites and ranked on the distance (in kb) from the gene
nearest to the binding site. Please note that in some instances, more than one
gene associates with a Kdm5c binding, resulting in a total percentage of more
than 100%.
See also Figures S1, S2, and S3.
C(Figures 2B and 2C). Please note that only 25 of the 6,656
Kdm5c peaks in NPC have a ChIP-seq score > 7; nine of
them have the MYC motif and five contain an ELK1 motif. The
correlation between GATA sites and Kdm5c binding is difficult
to determine because these sites occur frequently in the
mammalian genome.
Next, we examined the published c-MYC ChIP-seq data set
for ESCs (Chen et al., 2008) using the same criteria as for
Kdm5c. Of the 3,668 Kdm5c binding sites and 1,077 c-MYC
binding sites, 356 are overlapping. Other analyses (Figures
S3B and S3C) also showed a strong correlation between
Kdm5c and c-MYC binding in terms of ChIP-seq scores and
locations. Overlapping binding may result from a direct interac-
tion between Kdm5c and c-MYC protein, as indicated by coim-
munoprecipitation of these proteins after cotransfection in 293T
cells (Figure 2D). As expected (Secombe et al., 2007), Kdm5a
(and to a much lesser extent Kdm5b) also interacts with
c-MYC protein. Overrepresentation of the DNA-binding motifs
for ELK1 in Kdm5c regions (Figures 2A and 2C) may also result
from direct protein-protein interactions. Kdm5c and Kdm5b
(and to a lesser extent Kdm5a) coimmunoprecipitate with
transfected ELK1 protein (Figure 2E). In contrast to c-MYC and
ELK1, we could not detect Kdm5c interactions with GATA1,
GATA2, GATA4, or GATA6 in coimmunoprecipitation experi-
ments (data not shown). Recently, it was reported that recruit-
ment of Kdm5a and Kdm5b demethylases to transcribed regions
involves interaction with the chromo-domain protein MRG15
binding to H3K36me3 (Hayakawa et al., 2007; Xie et al., 2011).
In contrast to its family members, Kdm5c does not interact
with MRG15 (Figure S2C), and no Kdm5c peaks in the tran-
scribed regions are apparent in the ChIP-seq data set. Together,
our data indicate that c-MYC is a major recruiter for Kdm5c, and
that different members of the Kdm5 demethylase family display
distinct interaction profiles with several chromatin- or DNA-
binding proteins.
Knockdown of Kdm5c Results in Local Increases of
H3K4me3 and an Altered mRNA Expression Pattern
Recently, it was found that knockdown of Kdm5b expression in
mouse ESCs results in a strong increase in global H3K4me3 with
surprisingly little effect on mRNA expression (Schmitz et al.,
2011). To investigate the contribution of Kdm5c to H3K4 methyl-
ation levels, we created knockdown ESC lines using two
different small hairpin RNAs (shRNAs) against Kdm5c expressed
from lentiviruses (Figure 3A). Global H3K4me3 levels were not
affected by Kdm5c knockdown (Figure 3B), indicating that
Kdm5b, and not Kdm5c, is the predominant demethylase in
this cell system (Schmitz et al., 2011). This suggested a localized
function for Kdm5c, which we investigated by determining ChIP-
seq profiles for H3K4me3 and H3K4me1 after Kdm5c knock-
down. Indeed, analyses of these profiles revealed localized
increases in H3K4me3 and reductions in H3K4me1 modifica-
tions, both of which correlated with Kdm5c binding strength
(Figures 3C, 3D, S4, S5A, and S5B).
Parallel mRNA profiling by DNA microarrays revealed that
Kdm5c knockdown results in both activation and downregula-
tion of gene expression (Figure 4A). We investigated whether
this is correlated to the location of Kdm5c binding sites (Figuresell Reports 3, 1071–1079, April 25, 2013 ª2013 The Authors 1073
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Figure 2. Direct Protein Interactions of
Kdm5c with c-MYC and ELK1
(A) DNA motif enrichment analyses for the regions
of different H3K4me3 categories in ESCs. Values
on the y axis correspond to the log10 values of the
binominal uncorrected p values. No motifs were
enriched in regions of low H3K4me3.
(B) Proportion of Kdm5c peaks with an E-box
(CACGTG) binding site for c-MYC. The dashed line
indicates the approximate threshold for significant
Kdm5c-binding sites (FDR < 0.05; see Extended
Experimental Procedures).
(C) Proportion of Kdm5c peaks with the ELK1motif
([GC]CGGAAG[CT] in both orientations) shown on
the y axis.
(D) Interaction of GFP-fused Kdm5a, Kdm5b, and
Kdm5c with c-MYC protein in HEK293T extracts.
GFP fusions were precipitated using anti-GFP
beads and analyzed with the indicated antibodies.
(E) Interaction of GFP fusions with ELK1.
See also Figures S2 and S3.4B and 4C). Interestingly, genes associated with Kdm5c binding
sites in their promoters that contain high H3K4me3 (as deter-
mined in Figure 1B) are predominantly upregulated. In sharp
contrast, genes with distal enhancer-like binding sites (interme-
diate- and low-H3K4me3 regions in Figure 1B are combined) are
predominantly downregulated. This effect was consistent for
both Kdm5c knockdown cell lines.
Regulatory regions such as promoters and enhancers are
marked by an increased accessibility for DNase1 (Buecker and
Wysocka, 2012; Bulger and Groudine, 2011; Thurman et al.,
2012). We compared our Kdm5c ChIP-seq data with a public
ENCODE data set for DNase1 hypersensitive sites in mouse
ESCs (Figure 4D). Strikingly, binding of Kdm5c in both the high
and intermediate H3K4me3 regions strongly correlated with
DNase1 hypersensitivity. This supports the notion that the inter-
mediate H3K4me3 regions represent enhancers. Together with1074 Cell Reports 3, 1071–1079, April 25, 2013 ª2013 The Authorsthe Kdm5c knockdown, these results
suggest a model in which this demethy-
lase acts as a transcriptional repressor
at promoter sites to restrict mRNA output
and as an activator tomaintain the activity
from enhancer elements.
Kdm5c Acts As an Activator of
Enhancer Function and aRepressor
of Promoter Activity
We decided to test this model directly
in transient assays for promoter and
enhancer activity in ESCs. To this end,
selected Kdm5c binding regions with an
average size of 450 bp (270–693 bp;
Table S1; Figures 5A and S5C) were
cloned in two luciferase reporters:
pGL3-basic for promoter activity and
pPou5F1 for enhancer activity (with
a minimal Oct4-promoter active in
ESCs). One of the selected loci corre-sponded to Kdm5c binding at two previously documented
enhancers at the Gata2 locus (Grass et al., 2006) and is shown
in Figure 5A. Genomic screenshots of the other tested regions
are shown in Figure S5C. In agreement with our hypothesis,
Kdm5c knockdown reduced the enhancer activity of these
regions in the pPou5F1-derived constructs (Figure 5B), and in
most cases their activity was increased as a promoter element
in pGL3 (Figure 5C). TFIID binding is a hallmark of active
promoters and can bind directly to the H3K4me3 mark via its
TAF3 subunit (Vermeulen et al., 2007). Indeed, Kdm5c knock-
down increased the ChIP signal of TAF1, the largest subunit of
TFIID, at most of the tested enhancer and promoter regions (Fig-
ure 5D). Together, our data show that by removingH3K4me3, the
Kdm5c demethylase restricts TFIID binding, thereby regulating
transcription complex assembly at both promoter and enhancer
sites.
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Figure 3. Knockdown of Kdm5c Affects H3K4me1 and H3K4me3
Levels around the Kdm5c Binding Sites
(A) qRT-PCR analysis of Kdm5c mRNA levels upon lentiviral knockdown.
(B) Immunoblot analysis of Kdm5c protein levels and global levels of the
H3K4me3 upon stable knockdown. Two independent Kdm5c-targeting
shRNAs (shKdm5c#1: 3812, and shKdm5c#2: 3813) and a nontargeting
control shRNAwere used. The parental ESC line (IB10) served as an additional
control.
(C) The levels of H3K4me1 and H3K4me3 as defined by a ChIP-seq analysis
within 500 bp of the Kdm5c peaks change upon Kdm5c knockdown. The fold
change is dependent on the strength of Kdm5c binding as indicated by the
Kdm5c ChIP-seq score. Values on the y axis represent the average ratios of
H3K4me3methylation in Kdm5c knockdown over nontargeting shRNA control
cells. The dashed line indicates the threshold for significant Kdm5c binding
sites (FDR < 0.05).
(D) Upper panel: Genome browser screenshot of the Tfdp1 locus where
a highly localized increase of the H3K4me3 levels in region A is observed in the
ChIP-seq experiment. Lower panel: The data obtained from the ChIP-seq
experiment were confirmed in an independent ChIP-qPCR experiment with
three primers sets, indicated as A, B, and C. Data are presented asmean ± SE.
The significance of differences in H3K4me3 levels was determined by an
unpaired t test of the Kdm5c knockdown cell lines against the control shRNA
cell line (*p < 0.05, **p < 0.001).
See also Figures S4, S5, and Table S2.
CDISCUSSION
Distinct methylation states of histone H3K4 correlate with the
transcriptional roles of underlying DNA elements. Our study
reveals that the H3K4 demethylase Kdm5c is involved in speci-
fying the functional identity of transcription regulatory DNA
elements in the genome. Although Kdm5c can be recruited to
both promoter and enhancer elements via gene-specific tran-
scription factors (e.g., ELK1 and c-MYC), the transcriptional
responses upon knockdown of Kdm5c expression are predom-
inantly dependent on the initial H3K4 methylation state. In pla-
ces with a high H3K4me3 level (i.e., gene promoters), Kdm5c
binding acts to limit levels of H3K4me3, which leads to a reduced
binding of activator complexes, such as TFIID and possibly
others (Ruthenburg et al., 2007; Shilatifard, 2008; Vermeulen
et al., 2007; Wysocka et al., 2006), and hence restricts transcrip-
tion. Thus, Kdm5c has a repressive role at promoter sites similar
to that of its paralogs, Kdm5a and Kdm5b (Blair et al., 2011). In
contrast, at sites with relatively high levels of H3K4me1 (gene
enhancers), Kdm5c maintains this modification state by
removing spurious H3K4me3/2 modifications. This would
prevent inappropriate loading of transcription complexes, which
would compete with their binding to the nearby promoter. It is
interesting to note that of the small set of genes (185) with
Kdm5c peaks at both a promoter-proximal and a promoter-
distal position, 11 are downregulated upon Kdmc5c knockdown
and none are upregulated (data not shown). Taken together, our
findings indicate that Kdm5c activity supports enhancer func-
tion, which would be consistent with the previous classification
of its Drosophila paralog, Lid, as a Trithorax-group gene (Eissen-
berg et al., 2007; Gildea et al., 2000). This indicates that failure to
remove H3K4 methylation affects developmental mRNA expres-
sion programs.
Whyte et al. (2012) recently found that Lsd1 is required for
silencing of enhancers during differentiation of ESCs and
is essential for complete shutdown of ESC-specific genes.
Possibly, Kdm5 family members such as Kdm5b (Dey et al.,
2008; Schmitz et al., 2011) and Kdm5c (this work) collaborate
with Lsd1 to erase H3K4 methylation during ESC differentia-
tion, allowing switching of gene expression programs and tran-
sition to new cell states. Together, these findings raise ques-
tions about the stability of H3K4 methylation. Although global
turnover seems to be low (Zee et al., 2010), localized H3K4
methylation may be much more dynamic. Analogously to
histone deacetylases (Wang et al., 2009) and in support of
a dynamic turnover, the Kdm5a (Peng et al., 2009), Kdm5b
(Schmitz et al., 2011), and Kdm5c (Figures 1B and 1C) deme-
thylases colocalize with their substrates at active promoters.
To determine local turnover of H3K4me3/2 states and their
direct effects on transcription methylation, inhibitors targeting
the Kdm5 demethylases and/or the SET1/MLL methyltrans-
ferases are needed.
The proposal that histone H3K4methylation controls develop-
mental switches is further supported by the observation that
loss-of-function mutations in the human KDM5c gene are caus-
ative of X-linkedmental retardation (Blair et al., 2011). In addition,
somatic mutations of KDM5C in humans are linked to renal
cancers (Dalgliesh et al., 2010). We propose that some ofell Reports 3, 1071–1079, April 25, 2013 ª2013 The Authors 1075
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Figure 4. Transcriptional Responses upon
Kdm5c Knockdown Depend on the Initial
Chromatin State
(A) Heat map of the significantly changing genes
that overlap in both Kdm5c knockdown cell lines,
analyzed for each cell line in quadruple.
(B) Significantly changing genes (microarray,
p < 0.05) associated to the Kdm5c binding regions
with high and intermediate/low H3K4me3 levels
are shown for the shKdm5c#1(3812) knockdown
cell line. Significance levels of p < 0.05 between the
gene expression changes of the high-H3K4me3
and intermediate/low-H3K4me3-region-associ-
ated genes are indicated with a star. The red lines
indicate the mean values. Duplicates of multiple
regions associated with the same gene were
removed.
(C) Same as in (B) but for the shKdm5c#2(3813)
knockdown cell line.
(D) Clustering of the DNase1 sensitivity peaks from
mouse ESCs (ES-E14 ENCODE data set NCBI
GEO: GSM1014154) around the Kdm5c binding
sites with high, intermediate, and low H3K4me3
levels. The right lane compares transcriptional
responses to Kdm5c knockdown of the nearest
gene as defined in the Extended Experimental
Procedures. Color code: gray, genes did not
change significantly (p > 0.05); red, genes were
significantly upregulated (p < 0.05); and green,
genes were significantly downregulated (p < 0.05)
genes. White indicates that no gene could be
associated with this region.the effects of these KDM5C mutations relate to a disrupted
enhancer function. Enhancers were identified more than three
decades ago (Banerji et al., 1981), but the chromatin modifica-
tions that distinguish these elements from promoters were
recognized only recently (Buecker and Wysocka, 2012; Heintz-
man et al., 2009). This distinction may not be as clear-cut, since
active enhancers in primary lymphocytes and neurons are
also associated with H3K4me3 and pol II (Kim et al., 2010;
Pekowska et al., 2011). Moreover, enhancer-associated pol II
may not be a by-product of chromatin loops (Bulger and Grou-
dine, 2011; Ong and Corces, 2011), as enhancer-derived RNAs
resulting from bidirectional initiation events have been detected
(Core et al., 2008; Kim et al., 2010; Koch and Andrau, 2011; Ko-
walczyk et al., 2012). Such enhancers can act as alternative1076 Cell Reports 3, 1071–1079, April 25, 2013 ª2013 The Authorstissue-specific promoters (Kowalczyk
et al., 2012), which may be controlled by
the H3K4 methylation status. Accord-
ingly, we find that loss of Kdm5c can
activate a latent promoter activity in
enhancers.
An implication of enhancer control by
Kdm5c is that this demethylase would
act in concert with the H3K4 methyla-
tion enzymes to functionally catalog
genomic regions destined for enhancer
or promoter function. The highly localized
effects of Kdm5c reducing the H3K4me3state to H3K4me1 demonstrate that Kdm5c is not primarily
responsible for establishing H3K4me1 states, but dynamically
modulates H3K4me3 levels in regions that are targeted by
the H3K4 methyltransferases. Recent results in Drosophila
suggest that the MLL3/4 complexes are involved in estab-
lishing the H3K4me1 state in mammals (Herz et al., 2012).
Interestingly, systematic sequencing in renal carcinoma, char-
acterized by inactivating mutations mostly in the VHL gene,
identified additional gene mutations in KDM5C, MLL2, and
the KDM6A/UTX H3K27me3 demethylase gene, whose protein
product is part of MLL3 and MLL4 complexes (Dalgliesh et al.,
2010; Lee et al., 2007).
Overall, our work provides insight into the modulation
and establishment of the different H3K4 methylation states
AB
C
D
Figure 5. Kdm5c Is a Negative Regulator of Promoter Activity and
a Positive Regulator of Enhancer Activity
(A) Genome browser screenshot of the Kdm5c binding sites in theGata2 locus
together with H3K4me1, H3K4me3, and DNase1 hypersensitivity profiles. The
regions analyzed in the luciferase experiments are encircled by a dotted
ellipse.
(B) Normalized firefly luciferase activity in ESCs transfected with enhancer
constructs containing the Kdm5c binding sites in front of the Oct4 minimal
promoter (pPou5F1) in both the control and Kdm5c knockdown cell lines.
(C) Promoter activity of constructs of the same Kdm5c binding sites, driving
expression of the firefly luciferase construct lacking promoter sequences
(pGL3-basic).
Cthroughout the genome, the functional specification of en-
hancers and promoters, and the dynamics of H3K4 methylation
states.
EXPERIMENTAL PROCEDURES
Cell Culture and BAC Recombineering
IB10 (E14-ESC) and its derivative BirA (Driegen et al., 2005) mouse ESCs were
cultured on gelatin-coated dishes under standard conditions. A Kdm5c con-
taining bacterial artificial chromosome (BAC: #RP23-391D18) was obtained
from the BACPAC Resources Center (http://bacpac.chori.org). The triple-tag
V5-FLAG-BIO cassette was inserted as a C-terminal in-frame fusion using
BAC recombineering (Poser et al., 2008) BirA ESCs were transfected with
the recombineered BAC using Lipofectamine 2000 (Invitrogen) and selected
on geneticin (G418 sulfate; GIBCO). BirA and transgenic derivatives containing
the tagged Kdm5c gene were differentiated into NPCs using the procedure
described in Conti et al. (2005). Cos7 and HEK293T were cultured using stan-
dard conditions.
ChIP-Seq Data analysis
All of the ChIP-seq experiments were performed in triplicate and analyzed in
a single lane on Hiseq2000. Sequence reads were mapped to the unmasked
M. musculus genome (NCBI37; ftp://ftp.ncbi.nih.gov/genomes/M_musculus)
using the SOAPv2 program (Ruffalo et al., 2011), allowing a maximum of two
mismatches. Read-enriched regions were detected using CSAR (Muin˜o
et al., 2011). Essentially, uniquely mapped reads were extended directionally
200 bp. Low-coverage regions in the control with fewer than a minimum of
eight extended reads were set to this number for both Kdm5c ESCs and
NPCs. Enrichment of sample to control was calculated using a ratio score.
FDR thresholds were estimated by permutation of reads between the IP
sample and control. Based on an FDR < 0.05, the thresholds were 2.45
for the ESC and 2.24 for the NPC line. Primers for ChIP-PCR are listed in
Table S2.
Antibodies
H3K4me3 (05-745R [Millipore] for ChIP-seq or ab8580 [Abcam] for ChIP-
quantitative PCR [ChIP-qPCR]), H3K4me1 (pAb-037-050; Diagenode) or H3
(ab1791; Abcam), Nanog (A300-397A-I; Bethyl), Nestin (611658; BD Bio-
siences), Kdm5c (A301-034A; Bethyl), GFP (11814460001; Roche), V5
(combined clones 5C5 and 10D11, a gift from Dr. Dies Meijer, Rotterdam),
TAF1 (ab51540; Abcam), Lin28 (ab460200; Abcam), and MYC (05-724, clone
4A6; Millipore) antibodies were used in this study.
Data analysis
Significantly enriched Kdm5c-binding regions (FDR < 0.05) were compared
with published data sets (see Results section) using seqMINER (Ye et al.,
2011). Genes associated to Kdm5c binding sites (FDR < 0.05) were identified
with GREAT (McLean et al., 2010) using standard basal plus extension search
settings (proximal 5 kb upstream, 1 kb downstream, plus distal up to 1,000 kb).
Motif enrichments within 1 kb of a Kdm5c-binding site were determined using
GREAT.
Further detailed information can be found in the Extended Experimental
Procedures.
ACCESSION NUMBERS
Raw data and .wig files can be found in the Gene Expression Omnibus (GEO)
under accession number GSE34975. Microarray data have been deposited in
ArrayExpress under accession number GSE38862.(D) Knockdown of Kdm5c results in increased binding of TFIID. The presence
of TAF1 protein on the selected loci Kdm5c binding loci was quantified by
ChIP-qPCR. Data are presented as mean ± SD.
See also Figure S5 and Tables S1 and S2.
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